Moreover, overexpression of miR-125b inhibited cell growth and reduced migration and invasion in breast cancer cells through suppression of ERBB2 (erythroblastic leukemia viral oncogene homolog 2) and ERBB3 in breast cancer cells [31]. Here, ERBB2 is linked to breast carcinoma.